Anat Ashkenazi is Senior Vice President and Chief Financial Officer for Eli Lilly and Company. Since joining Eli Lilly in 2001, she has held a range of roles across strategy, finance and Six Sigma. Most recently, she served as Senior Vice President, Controller and CFO of Lilly Research Laboratories. In this role, Ms. Ashkenazi oversaw the CFOs of the company’s commercial businesses, as well as those for research and development, manufacturing and quality, and G&A functions. She also led the corporate strategic planning team, business transformation office, and served as CFO for several of the company’s global business areas. Prior to joining Eli Lilly, she worked in financial services at Ma’alot Standard & Poor’s and at Ha’poalim Bank in Israel.
Ms. Ashkenazi earned a bachelor’s degree from the Hebrew University in finance and economics and a Master of Business Administration from Tel Aviv University. She currently serves on the board of directors at Maravai Life Sciences. She previously served on the board of directors for Varian Medical Systems, a market leader in radiation therapy.